Clinical Trial Update: A Trial to Investigate Benralizumab in Children With Eosinophilic Diseases [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is recruiting to evaluate benralizumab in children with eosinophilic diseases including eosinophilic granulomatosis with polyangiitis a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Granulomatosis with Polyangiitis
• Hypereosinophilic Syndrome

Drugs mentioned

• Benralizumab (benralizumab)

Snippet

Sponsor: AstraZeneca | Conditions: Eosinophilic Granulomatosis With Polyangiitis (EGPA), Hypereosinophilia Syndrome (HES) | Phase 3 | Status: RECRUITING